#USA #financial results #Investments #San Clemente #Angelalign

Angelalign Technology's Impressive H1 2025 Results

San Clemente, California – August 26, 2025 – Angelalign Technology Inc. ("Angel" or "the Company") reported promising interim results for the first half of 2025, highlighting a robust performance amidst increased investments in crucial areas such as legal compliance, supply chain management, and data security.

In the first six months of 2025, Angelalign experienced a substantial revenue growth of 33.1%, reaching $161.4 million. The gross profit stood at $100.6 million, while the adjusted net profit was reported at $19.5 million. Moreover, the global volume of aligner units soared by 47.7% compared to the same period last year, totaling approximately 225,800 units.

This notable increase in shipments, alongside efficient operations at the treatment planning centers and aligner production facilities, significantly contributed to the rise in revenue, gross profit, and operating profits year-over-year. The Company also benefited from stringent expense management, particularly in anticipation of an uncertain tariff environment, which included delays in hiring specific sales and marketing, clinical support, and customer service staff, as well as delays in the operations of treatment planning and manufacturing centers outside mainland China.

Angelalign is strategically enhancing its long-term investments in several key areas to build a more sustainable international presence. The Company plans to amplify its spending on sales and marketing, clinical support, customer service, and the establishment and operation of treatment planning centers and production sites outside China. Additionally, Angelalign aims to strengthen its legal capabilities in supporting its strategy and intellectual property (IP) compliance while further modernizing its data security infrastructure.

Outside of mainland China, unit sales for Angelalign increased dramatically by 103.5% compared to the same period last year, reaching 117,200 units. This strong growth reflects both a low base from the previous year and initial successes in new markets. The Company expanded its outreach by delivering high-quality treatment planning, ensuring reliable supply chains, and implementing continuous educational programs with key opinion leaders.

In mainland China, Angelalign's volume grew by 14% year-on-year, amounting to about 108,600 units. The Company has adopted a forward-thinking growth strategy, focusing on early orthodontic treatment and developing markets as crucial drivers for sustainable growth.

Throughout H1 2025, Angelalign introduced innovative products and solutions targeting early orthodontic treatments and complex cases. The Company integrated smart initial consultation tools and treatment monitoring instruments into their offerings, collaborating with several universities to foster key clinical innovations.

The Company's commitment to IP strategy and compliance remains a top priority. As Angelalign expands its global footprint, significant investment in strengthening its legal capabilities has been made. The Company is dedicated to continuing its history of innovative products while actively protecting its intellectual property rights.

To meet the growing market demand, Angelalign is building a world-class intelligent manufacturing system focused on user orientation, environmental sustainability, and scalability. The Company plans to create or expand production and treatment planning capacities in key locations around the world, ensuring timely and stable product and service delivery to clients globally. For instance, treatment planning centers in Brazil and Southeast Asia are currently providing planning services that cater to the U.S. market.

Additionally, Angelalign has allocated substantial resources for upgrading its data security infrastructure and operational processes to ensure compliance with data safety regulations and privacy standards across all major markets. This represents significant investments and remains a steadfast objective of the Company.

Fox Hu, CEO of Angelalign, stated, "We remain confident in the long-term growth prospects of the global aligner industry. Key priorities include scaling aligner production and treatment plans, expanding clinical capabilities, continuing our history of product innovation with adequate IP protection, and increasing investments in compliance while ensuring sustainable growth in all regions.”

About Angelalign Technology Inc.
Founded in 2003 and having delivered 1.5 million smiles, Angelalign Technology Inc. provides digital technology-based products and services to meet the needs of dentists and patients worldwide. The Company’s innovative products and technical services have made it a significant player in the orthodontic industry. In 2021, Angelalign Technology Inc. was listed on the Hong Kong Stock Exchange, and it launched its global expansion strategy in 2023, with its products and services now covering over 50 countries and regions. For more information, visit angelaligner.com.